In the BioHarmony Drug Report Database

"Preview" Icon

Lamivudine

Epivir, Epivir-hbv, Zeffix (lamivudine) is a small molecule pharmaceutical. Lamivudine was first approved as Epivir on 1995-11-17. It is used to treat acquired immunodeficiency syndrome, hepatitis b, and HIV infections in the USA. It has been approved in Europe to treat chronic hepatitis b and HIV infections.

 

Trade Name

 

Epivir, Zeffix
 

Common Name

 

lamivudine
 

ChEMBL ID

 

CHEMBL141
 

Indication

 

acquired immunodeficiency syndrome, chronic hepatitis b, hepatitis b, hiv infections
 

Drug Class

 

Antineoplastics,antivirals (zidovudine group) (exception: edoxudine)

Image (chem structure or protein)

Lamivudine structure rendering